ListarArtículos (Medicina) por materia "EGFR mutations"
Mostrando ítems 1-1 de 1
-
Artículo
Impact of smoking status on the relative efficacy of the EGFR TKI/ angiogenesis inhibitor combination therapy in advanced NSCLCda systematic review and meta-analysis
(ESMO open, 2022)Background: The ETOP 10-16 BOOSTER trial failed to demonstrate a progression-free survival (PFS) benefit for adding bevacizumab ...